AORT today
$20.10-$0.37 (-1.81%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minSymmetric Triangle
5 minStrong Bearish
Daily trend turns up above $39.66
Key levels
Resistance$21.85
Resistance$20.21
Support$18.38
Support$16.48
Latest news & SEC filings
AnalystCanaccord Genuity keeps Buy rating on Artivion, cuts target to $30
AnalystCitizens keeps Market Outperform on Artivion, cuts price target to $42
All AORT news →About Artivion
Artivion develops, produces and sells medical devices and preserved donor grafts used in heart and blood vessel operations, primarily to treat aortic conditions. Its offerings include stent grafts for the aorta, On-X mechanical heart valves, surgical adhesives, and cryopreserved cardiac and vascular tissue. The company serves heart and vascular surgeons, with operations in the United States and other countries.
Based on the company's 10-K filed Feb 18, 2026.
NYSE · Healthcare
ARTIVION, INC. (AORT)
What Is the Price Target for AORT?
SEPT Low Target
$31.00
SEPT Mid Target
$44.00
SEPT High Target
$48.00
Analyst Consensus
$44.00
Is AORT a Buy or Sell Right Now?
Thesis
- •Revenue growing 13.6% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AORT.
Start Free Trial →Is AORT Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$39.00
41
Moat Score
NARROW
7/9
Piotroski Score
2.4
Altman Z-Score
What Is Smart Money Doing with AORT?
Insider Signal
SELLING
0 buys / 8 sells (90d)
Congress Signal
BUYING
3 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| GREEN ANDREW M | officer | Sale | 11,480 | $287K | Sep 10, 2026 |
| GREEN ANDREW M | officer | Sale | 1,493 | $39K | Sep 3, 2026 |
| GREEN ANDREW M | officer | Sale | 6,510 | $177K | Sep 2, 2026 |
| GREEN ANDREW M | officer | Buy | 14,001 | $258K | Jun 11, 2026 |
| GREEN ANDREW M | officer | Sale | 14,001 | $290K | Jun 11, 2026 |
| GREEN ANDREW M | officer | Buy | 30,000 | $331K | Jun 11, 2026 |
| GREEN ANDREW M | officer | Sale | 30,000 | $621K | Jun 11, 2026 |
| SEMEDO ANTHONY B. | director | Sale | 6,325 | - | Jun 2, 2026 |
| Borgstrom Marna P | director | Buy | 7,576 | - | May 18, 2026 |
| SEMEDO ANTHONY B. | director | Buy | 7,576 | - | May 18, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AORT Growth Story
Revenue YoY
13.6%
3yr Revenue CAGR
12.0%
EPS Growth YoY
165.62%
FCF Growth YoY
-92.4%
Revenue Trend
STABLE
Dark Pool Trades for AORT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for AORT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:36 | $20.10 | 1,800 | $$36K | BUY |
| 21:00:36 | $20.10 | 6,777 | $$136K | BUY |
| 21:00:36 | $20.10 | 1,100 | $$22K | BUY |
| 21:00:35 | $20.10 | 1,969 | $$40K | BUY |
| 21:00:35 | $20.10 | 2,029 | $$41K | BUY |
5 dark pool trades shown · $$275K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for ARTIVION, INC. (AORT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AORT — frequently asked questions
What is AORT stock price today?
ARTIVION, INC. (AORT) is at $20.10, down 1.81% (-$0.37) at the Nov 11, 2026 close.
Why is AORT stock moving today?
Latest AORT news — Nov 6, 2026: Canaccord Genuity keeps Buy rating on Artivion, cuts target to $30 · Nov 6, 2026: Citizens keeps Market Outperform on Artivion, cuts price target to $42
What is the AORT price target?
The average analyst price target for AORT is $44.00, ranging from $31 to $48, based on 5 analysts. Latest: Jefferies upgrade on Oct 20, 2026.
What do analysts rate AORT?
Analyst ratings for AORT: 1 Buy, 5 Hold, 0 Sell — consensus Hold.
Did AORT beat earnings?
AORT last reported on Aug 6, 2026: EPS -$0.28 vs $0.00 expected — a miss of 11300.0%.
Does AORT pay a dividend?
AORT does not currently pay a dividend.
How much debt does AORT have?
ARTIVION, INC. reported $363M of debt and $77M of cash (Jun 30, 2026).
What are AORT support and resistance levels?
Support: $18.38, $16.48. Resistance: $20.21, $21.85, $23.69.
What are insiders doing with AORT?
Insider activity: SELLING, 0 buys and 8 sells in the last 90 days.
What is the latest news on AORT?
Nov 6, 2026: Canaccord Genuity keeps Buy rating on Artivion, cuts target to $30 · Nov 6, 2026: Citizens keeps Market Outperform on Artivion, cuts price target to $42